Skip to content

Alkaline Phosphatase

by Abbott Laboratories Diagnostics Division

510(k) K240468

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK240468 Date16 Oct 2024ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CJE
Device Class
Class II
Regulation
21 CFR Part 862.1050
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Alkaline Phosphatase is an in vitro diagnostic device used for measuring alkaline phosphatase enzyme activity in serum or plasma samples. It falls under the category of biochemical analyzers and is designed to assist in the diagnosis and monitoring of conditions affecting bone metabolism, liver disease, and other clinical indications where elevated or altered enzyme levels may be relevant.

This device is intended for single-use in clinical chemistry laboratories and requires no sterilization beyond standard laboratory practices. It is classified as a Class II medical device under FDA regulations (21 CFR 862.1050) and received Special 510(k) clearance (K240468) on October 16, 2024. Supplied as a reagent for use with compatible automated or semi-automated biochemical analyzers, it is not intended for MRI use and must be stored according to manufacturer instructions to maintain stability and accuracy.

Other devices from Abbott Laboratories Diagnostics Division

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical conditions is the Alkaline Phosphatase reagent used to diagnose or monitor?

    This reagent measures alkaline phosphatase enzyme activity in serum or plasma, aiding in the diagnosis and monitoring of conditions like bone metabolism disorders (e.g., Paget’s disease, rickets) and liver diseases (e.g., cholestasis, cirrhosis). Elevated or altered enzyme levels can indicate these conditions, making it a key tool for clinicians assessing organ function or metabolic health.

  • How is the Alkaline Phosphatase reagent supplied, and what equipment does it require?

    The reagent is supplied as a single-use component designed exclusively for use with compatible automated or semi-automated biochemical analyzers in clinical chemistry laboratories. It is not a standalone device and must be paired with the appropriate analyzer system to perform measurements. The reagent is not intended for manual testing or use outside of these automated platforms.

  • Is the Alkaline Phosphatase reagent sterile, and what are the storage requirements?

    The reagent is intended for single-use in clinical settings and does not require additional sterilization beyond standard laboratory practices. To maintain stability and accuracy, it must be stored according to the manufacturer’s instructions, which typically include protecting it from extreme temperatures, light exposure, and contamination. Always refer to the accompanying documentation for specific storage conditions.

  • Can the Alkaline Phosphatase reagent be reused, or is it designed for one-time use?

    This reagent is explicitly designed for single-use only. Reusing it could compromise test accuracy, introduce contamination, or violate manufacturer guidelines, potentially leading to unreliable diagnostic results. Single-use ensures consistency and safety in clinical chemistry applications.

  • What regulatory pathway was followed for the Alkaline Phosphatase reagent’s clearance?

    The reagent received Special 510(k) clearance (K240468) from the FDA on October 16, 2024, under the classification of a Class II medical device (21 CFR 862.1050). This pathway was used to demonstrate that the device is substantially equivalent to a legally marketed predicate device, ensuring it meets safety and performance standards for clinical use in measuring alkaline phosphatase activity.